MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation

Clinical trial NCT02250300 · COMPLETED

Trial details

NCT number: NCT02250300
Sponsor: Mehdi Hamadani
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation

Start date: 2014-11-19
Primary completion: 2020-10-06
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.